Page last updated: 2024-11-06

prednisolone and Plasmodium vivax Malaria

prednisolone has been researched along with Plasmodium vivax Malaria in 3 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Research Excerpts

ExcerptRelevanceReference
"Prednisolone was then tapered and stopped."1.37Auto-immune haemolytic anaemia concurrent with Plasmodium vivax infection: a case report. ( Anurathapan, U; Chanthavanich, P; Sirachainan, N; Sitcharungsi, R, 2011)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Purkait, R1
Mukherji, A1
Sinhamahapatra, T1
Bhadra, R1
Ghosh, A1
Sharma, S1
Choudhury, J1
Sitcharungsi, R1
Anurathapan, U1
Sirachainan, N1
Chanthavanich, P1

Other Studies

3 other studies available for prednisolone and Plasmodium vivax Malaria

ArticleYear
Acute Disseminated Encephalomyelitis in a Child Following Plasmodium vivax Malaria.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2015, Volume: 25, Issue:7

    Topics: Child; Encephalomyelitis, Acute Disseminated; Female; Glucocorticoids; Humans; Magnetic Resonance Im

2015
Autoimmune Hemolytic Anemia in Plasmodium vivax Malaria.
    Indian journal of pediatrics, 2017, Volume: 84, Issue:6

    Topics: Anemia, Hemolytic, Autoimmune; Antimalarials; Artemisinins; Artesunate; Blood Transfusion; Glucocort

2017
Auto-immune haemolytic anaemia concurrent with Plasmodium vivax infection: a case report.
    Annals of tropical paediatrics, 2011, Volume: 31, Issue:1

    Topics: Anemia, Hemolytic, Autoimmune; Antimalarials; Chloroquine; Humans; Immunosuppressive Agents; Infant;

2011